Skip to main content
. 2021 Nov 11;61(7):2894–2904. doi: 10.1093/rheumatology/keab827

Fig. 2.


Fig. 2

The MFI of CD20 and FcγRIIb on B cells from patients with RA and SLE

(A) The frequency of CD20+ B cells in patients with RA and SLE; (B) the MFI of CD20 in patients with RA and SLE; (C) the MFI of FcγRIIb in patients with RA and SLE; and (D) the ratio of MFI of CD20 and MFI of FcγRIIb of CD20+ B cells from patients with RA and SLE. MFI, mean fluorescence intensity; *P < 0.05; ***P < 0.0001; ns: not significant.